# Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)

> **NCT04222309** · PHASE1 · SUSPENDED · sponsor: **Northwell Health** · enrollment: 10 (estimated)

## Conditions studied

- Glioma
- Glioma, Malignant
- Glioblastoma
- Glioblastoma Multiforme
- Glioblastoma Multiforme of Brain
- GBM
- Brain Cancer

## Interventions

- **PROCEDURE:** Laparoscopically harvested omental free flap

## Key facts

- **NCT ID:** NCT04222309
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-01-06
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 10 (ESTIMATED)
- **Why stopped:** Per IRB closed and opened a new study.
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04222309

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04222309, "Laparoscopically Harvested Omental Free Tissue Autograft to Bypass the Blood Brain Barrier (BBB) in Human Recurrent Glioblastoma Multiforme (rGBM)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04222309. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*